Neocannbio Co., Ltd. has been selected for the 2022  Proof of Concept and Commercialization Support Program for Regulatory Sandbox Company organized by the Seoul Business Agency, and has received support for the ongoing production of bGMP-based production of high-purity cannabidiol (CBD) raw materials and new drug development.